| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 32 |
| 1 | METHOTREXATE SODIUM | 32 |
| 2 | CYTARABINE | 24 |
| 3 | FLUCONAZOLE | 21 |
| 4 | PREDNISONE | 20 |
| 5 | VENETOCLAX | 18 |
| 6 | CYCLOPHOSPHAMIDE | 17 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 9 | HYDROCORTISONE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 10 | 0.0291 |
| 1 | DEXRAZOXANE FOR INJECTION | 11 | 0.0117 |
| 2 | REZAFUNGIN | 1 | 0.0099 |
| 3 | UNDECYLENIC ACID | 1 | 0.0072 |
| 4 | TOLNAFTATE 1% | 1 | 0.0034 |
| 5 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 6 | I. V. FAT EMULSION | 1 | 0.0014 |
| 7 | MITOMYCIN | 5 | 0.0014 |
| 8 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 9 | MOSUNETUZUMAB | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 77 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 3 | Azole Antifungal [EPC] | 31 |
| 4 | Alkylating Drug [EPC] | 26 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 6 | BCL-2 Inhibitor [EPC] | 18 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 8 | Asparagine-specific Enzyme [EPC] | 14 |
| 9 | Benzodiazepine [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 14 | 0.0010 |
| 1 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 2 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 3 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 4 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 6 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 8 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 9 | BCL-2 Inhibitor [EPC] | 18 | 0.0003 |